Holen Sie sich die Stockscreener-App
2.045
2.62%
-0.055
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus
Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock - Investing.com
Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock By Investing.com - Investing.com Nigeria
Form 4 Processa Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Insider purchase: Processa (NASDAQ: PCSA) CAO adds 2,436 shares in open-market buy - Stock Titan
Processa (PCSA) strategy chief adds 2,106 shares in insider buy - Stock Titan
Processa Pharmaceuticals (PCSA) CEO adds 3,057 shares in open-market buy - Stock Titan
CFO of Processa (NASDAQ: PCSA) adds 3,277 shares in open-market buy - Stock Titan
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SKIBSTED RUSSELL - Moomoo
Processa Pharmaceuticals (PCSA) director buys 2,531 shares in open market - Stock Titan
Processa Pharmaceuticals, Inc. Financial Disclosures & SEC Filings - TradingView
Form 4 Processa Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Canada
Processa (NASDAQ: PCSA) director Yorke vests 203-share restricted stock award - Stock Titan
[Form 4] Processa Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Processa Pharmaceuticals (PCSA) director receives 203 shares from vesting - Stock Titan
Processa Pharmaceuticals (PCSA) director gets 203 shares from service award - Stock Titan
Price to sales forward of Processa Pharmaceuticals, Inc. – NASDAQ:PCSA - TradingView
Price to earnings forward of Processa Pharmaceuticals, Inc. – NASDAQ:PCSA - TradingView
Processa Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:PCSA) - TradingView
PCSA | Processa Pharmaceuticals, Inc. Common Executive Compensation - Quiver Quantitative
Shareholders to vote on Processa (NASDAQ: PCSA) equity plan and pay - Stock Titan
Processa Pharmaceuticals Inc (PCSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Processa Pharmaceuticals | DEF 14A: Definitive information statements - Moomoo
Processa Pharmaceuticals Inc (PCSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Processa Pharmaceuticals Inc (PCSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Processa Pharmaceuticals Inc - TradingKey
Processa Pharmaceuticals Inc (PCSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Processa Pharmaceuticals Inc (PCSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Processa Pharmaceuticals Inc (PCSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Processa Pharmaceuticals Inc (PCSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Processa Pharmaceuticals Inc (PCSA) Institutional Confidence - TradingKey
Processa Pharmaceuticals CFO Russell Skibsted buys $5,891 in stock By Investing.com - Investing.com UK
Processa Pharmaceuticals chief business officer Lin buys $4,064 stock By Investing.com - Investing.com India
Processa Pharmaceuticals CEO George Ng buys $5,472 in stock By Investing.com - Investing.com Australia
Processa Pharmaceuticals CFO Russell Skibsted buys $5,891 in stock - Investing.com
Processa Pharmaceuticals chief business officer Lin buys $4,064 stock - Investing.com UK
Processa Pharmaceuticals CEO George Ng buys $5,472 in stock - Investing.com UK
Processa Pharma president of R&D David Young buys $4,588 in stock - Investing.com Canada
Processa Pharma president of R&D David Young buys $4,588 in stock By Investing.com - Investing.com South Africa
Insider David Young adds 2,067 Processa (PCSA) shares at $2.22 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO buys 2,654 shares in open market - Stock Titan
Processa Pharmaceuticals (PCSA) CEO adds 2,465 shares in open-market buy - Stock Titan
Processa Pharmaceuticals (PCSA) officer adds 1,831 shares in open-market buy - Stock Titan
Processa Pharmaceuticals (PCSA) CAO buys 2,118 shares at $2.22 in open market - Stock Titan
PCSA Q4 2025 Earnings: EPS Misses Estimates by 67.97% as Pre-Revenue Biotech Faces HeadwindsWeak Earnings Momentum - newsline.com
Processa Pharmaceuticals, Inc. - MLQ.ai
PCSA Stock Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Processa Pharmaceuticals CAO Wendy Guy buys $4,700 in stock By Investing.com - Investing.com India
Processa Pharmaceuticals CAO Wendy Guy buys $4,700 in stock - Investing.com
Processa Pharmaceuticals’ pres. David Young buys $4,590 in stock By Investing.com - Investing.com India
Processa Pharmaceuticals chief business and strategy officer buys $4,065 in stock - Investing.com Nigeria
Processa Pharmaceuticals’ pres. David Young buys $4,590 in stock - Investing.com
1.88%
2.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):